IL5 (Reslizumab Biosimilar) Recombinant Monoclonal Antibody
-
貨號(hào):CSB-RA011662MB4HU
-
規(guī)格:¥83486
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:IL5(Reslizumab Biosimilar Antibody)重組單克隆抗體是一種針對(duì)白細(xì)胞介素-5(IL-5)的生物制劑,主要用于科研領(lǐng)域的免疫學(xué)及炎癥相關(guān)研究。該抗體通過特異性結(jié)合IL-5,可有效阻斷其與靶細(xì)胞表面受體的相互作用,進(jìn)而調(diào)控嗜酸性粒細(xì)胞的活化、增殖與存活過程。 在機(jī)制研究中,IL5(Reslizumab Biosimilar Antibody)重組單克隆抗體能夠精準(zhǔn)靶向IL-5信號(hào)通路,為探索過敏性疾病、哮喘及嗜酸性粒細(xì)胞增多癥等病理過程提供關(guān)鍵工具。通過抑制IL-5的生物學(xué)活性,該抗體有助于解析嗜酸性粒細(xì)胞在炎癥反應(yīng)中的作用機(jī)制,為相關(guān)疾病的病理機(jī)制研究奠定基礎(chǔ)。 該試劑適用于多種科研場(chǎng)景,包括體外細(xì)胞實(shí)驗(yàn)、動(dòng)物模型構(gòu)建及信號(hào)通路分析等。其高特異性和生物活性確保了實(shí)驗(yàn)結(jié)果的可靠性與可重復(fù)性,是免疫學(xué)、分子生物學(xué)及轉(zhuǎn)化醫(yī)學(xué)研究中的重要工具。 在使用過程中,需嚴(yán)格遵循科研實(shí)驗(yàn)規(guī)范,根據(jù)具體研究需求優(yōu)化抗體濃度及作用條件。該產(chǎn)品僅用于實(shí)驗(yàn)室研究,不用于臨床診斷或治療用途,旨在為生命科學(xué)領(lǐng)域的基礎(chǔ)研究與應(yīng)用探索提供支持。
-
Uniprot No.:
-
基因名:
-
別名:Anti-interleukin-5-monoclonal antibody-Celltech/Schering-Plough research-grade biosimilar; CDP-835 research-grade biosimilar; CEP-38072 research-grade biosimilar; Cinqaero research-grade biosimilar; Cinqair research-grade biosimilar; Cinquil research-grade biosimilar; CTX-55700 research-grade biosimilar; DCP-835 research-grade biosimilar; reslizumab research-grade biosimilar; Reslizumab (USAN) research-grade biosimilar; SCH-5570 research-grade biosimilar; SCH 55700 research-grade biosimilar; SCH-55700 research-grade biosimilar; TRFK-5 research-grade biosimilar ;IL5 antibody; Interleukin-5 antibody; IL-5 antibody; B-cell differentiation factor I antibody; Eosinophil differentiation factor antibody; T-cell replacing factor antibody; TRF antibody
-
反應(yīng)種屬:Human
-
免疫原:Recombinant Human IL5 protein
-
免疫原種屬:Homo sapiens (Human)
-
標(biāo)記方式:Non-conjugated
-
克隆類型:Monoclonal
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:0.01M PBS,pH7.4
-
產(chǎn)品提供形式:Liquid
-
應(yīng)用說明:Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method. -
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:3-4 weeks
-
用途:It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Factor that induces terminal differentiation of late-developing B-cells to immunoglobulin secreting cells.
-
基因功能參考文獻(xiàn):
- IL-5 is expressed intrathecally in tick-borne encephalitis, but its pathogenetic role remains unclear. PMID: 29602685
- eosinophilia in FE is secondary to dysregulation of IL-5 production in PBMC (and their component subsets). PMID: 28226398
- Data indicate that interleukin-5 (IL-5) was that only serum cytokines show statistical significance between severe chronic obstructive pulmonary disease (COPD) and controls. PMID: 28398462
- Serum IL-5 and IL-13 are reliable biomarkers for the blood eosinophilia asthma phenotype. PMID: 27060452
- Longitudinal co-variations between inflammatory cytokines, lung function and patient reported outcomes in patients with asthma PMID: 28915273
- Obesity alters the lung neutrophil infiltration to enhance breast cancer metastasis through IL5 and GM-CSF. PMID: 28737771
- simvastatin was demonstrated to inhibit IL-5-induced CCR3 expression and chemotaxis of eosinophils mediated via the mevalonate pathway. PMID: 27275740
- Interleukin-5/-targeted treatments offer promises to patients with eosinophilic respiratory disorders; review PMID: 26859368
- Data indicate that interleukin 5 (IL-5)-associated single nucleotide polymorphisms (SNPs) were not associated with carotid intima-media thickness. PMID: 26821299
- Post-liver transplant patients with food allergy showed a unique cytokine profile in response to various stimuli, with extremely elevated IL-5, low IL-10 secretion. PMID: 26282695
- Production of IL-5 in response to both extract and the Bet v1-derived peptide mix strongly suggested that T cells were a major source of IL-5. PMID: 25817862
- It has been shown in this study that the level of IL-5, one of the markers of eosinophilic inflammation, is higher in EBC of children with atopic asthma than in those with nonatopic asthma. PMID: 25937050
- IL-5 may be part of protective mechanisms operating in early atherosclerosis, at least in women PMID: 25587992
- Results showed that PAX2 expression is significantly overexpressed in esophageal squamous cell carcinoma tissues and IL-5 is identified as PAX2's effector for metastasis. PMID: 25613757
- Subsequent IL-5-stimulated signaling. PMID: 25121926
- increased levels in recurrent versus nonrecurrent rhinosinusitis with nasal polyps at the moment of the first surgery PMID: 24980230
- HDM-specific IL-5 responses at age 3 years or later are the best measure of T cell function for predicting asthma at age 8 years. PMID: 24875149
- Fibrocytes studied were generated in vitro from PBMCs by culturing in the presence of platelet derived growth factors and stimulated by IL-33. Fibrocytes constitutively expressed IL-13 and IL-5, which was augmented by stimulation with IL-33. PMID: 24822215
- Mechanisms of human eosinophil migration induced by the combination of IL-5 and the endocannabinoid 2-arachidonoyl-glycerol. PMID: 24530098
- Patients with the 'IL-5, IL-17A, IL-25-high' airway inflammatory pattern are often uncontrolled asthmatics, despite daily treatment. PMID: 23957336
- These unexpected results provide a theoretical basis for the therapeutic targeting of IL-5 in bladder cancer PMID: 23770289
- In activated eosinophils ligation of Siglec-8 leads to ROS-dependent enhancement of IL-5-induced ERK phosphorylation, which results in a novel mode of biochemically regulated eosinophil cell death. PMID: 23684072
- When patients were classified according to sputum IgE levels, it appeared that IL-5, IL-6, IL-17 and TNF-alpha sputum supernatant levels were raised in the "IgE high" asthmatics when compared to "IgE low" asthmatics PMID: 23555579
- alpha(M)beta(2) integrin-mediated adhesion and motility of IL-5-stimulated eosinophils on periostin. PMID: 23306834
- Type I interferon (IFN)-dependent inhibition of T cell-derived IL-5 is mediated by IFN-alpha acting directly on activated T cells. PMID: 23382558
- Strong IL-5 production was detected in response to peptides from several of the previously undescribed proteins of grass pollen. PMID: 23401558
- Topical steroid treatment may suppress IL-5 gene expression, and steroids may inhibit eosinophil functions in nasal polyps. PMID: 15835818
- Elevated expression of inflammatory cytokines (IL-5, IL-20, and IL-28A) is associated with bladder cancer development. PMID: 22962576
- binding of IL-5 to IL-5Ralpha plays a critical role in MMP-9 expression, which may be involved in the migration of bladder cancer. PMID: 22710862
- The study reports the crystal structure of dimeric IL-5 in complex with the IL5RA extracellular domains. PMID: 22528658
- Elevated levels of IL-5, which uses the neural plasticity-related RAS GTPase-ERK pathway to mediate its actions in the central nervous system, could be one of the factors underlying the depression-related changes in CNS plasticity. PMID: 22230487
- elevated levels in induced sputum from patients with asthma and allergic rhinitis PMID: 22186238
- REVIEW: Interleukin-5 and IL-5 receptor in health and disease PMID: 21986312
- The structure demonstrates that for steric reasons, homodimeric IL-5 can bind only one receptor molecule, even though two equivalent receptor-binding sites exist. PMID: 22153509
- There is no correlation between the eosinophilic infiltration and the expression of IL-5 in lung cancer tissues. PMID: 21609545
- Transplantation of human mesenchymal stem cells suppresses middle cerebral artery occlusion (MCAO) focal ischemia-induced inflammation, possibly through expression of fractalkine and interleukin (IL)-5. PMID: 21168500
- results demonstrate that IL-5(+) and IL-5(-) Th2 cells, respectively, represent more and less highly differentiated Th2 cell subpopulations PMID: 21849680
- IL-5 may play a role in the early phase of acute pneumonia caused by the 2009 H1N1 virus in Japanese children. PMID: 21323726
- Activation of GATA-3 might be one of the mechanisms for induction of IL-5 expression in chronic rhinosinusitis. PMID: 17628972
- AP-1 may participate in the signal transduction of PKC-triggered expression of IL-5 in allergic rhinitis T lymphocytes. PMID: 17438848
- PPD-induced preferential secretion by PBMCs of Warao indigenous patients in Venezuela PMID: 20650294
- Functional polymorphisms in the genes encoding the Th2 cytokines Il-5, IL-6, and IL-13, are associated differently with the development and prognosis of autoimmune thyroid disease from each other. PMID: 21235536
- IL-5 and IL-8 are the key cytokines in the formation of nasal polyps. PMID: 16929824
- Suggest that IL-5 responses in cord blood samples were strongly related to the season of birth. PMID: 20825427
- promotes increased immunoglobulin M at the site of disease in leprosy PMID: 20561085
- Our study identifies CXCL10 and IL-5 as proteins differentiating complicated and uncomplicated plaques from human carotid arteries PMID: 20943047
- Sputum IL-5 was associated with a sputum eosinophilia. PMID: 19478474
- data indicate that ability to produce the type 2 cytokines IL-13 and IL-5 defines CD161(+) NK cells at intermediate stages of differentiation, and is lost upon terminal functional differentiation, concomitant with acquired ability to produce IFN-gamma PMID: 11830476
- CD4(+) T cells are the major source of IL-5 among CD3(+) lymphocytes in atopic asthmatic subjects, whereas in nonatopic asthmatic subjects CD8 (+) T cells as well as CD4(+) T cells contribute to the increased production of IL-5 PMID: 11842300
- By itself, IL5 increases nerve growth factor level in eosinophils, but in combination with immune complexes, significantly reduces eosinophil NGF levels. PMID: 11877300
顯示更多
收起更多
-
亞細(xì)胞定位:Secreted.
-
蛋白家族:IL-5 family
-
數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















